Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes

Investigational New Drugs
William C ZamboniSharon Marsh

Abstract

The source of the pharmacokinetic variability of 9-nitrocamptothecin (9NC) and its 9-aminocamptothecin (9AC) metabolite is unknown. ATP-binding cassette (ABC) transporters have been reported to modulate camptothecin analogues, are associated with camptothecin resistance, and might also affect 9NC and 9AC pharmacokinetics. The aim of this study was to evaluate the functional consequence of known single nucleotide polymorphisms in the transporter genes ABCB1, ABCC2, and ABCG2 on the pharmacokinetic disposition of 9NC and 9AC. Pharmacokinetic and genotyping studies were performed in 55 patients as part of two phase I studies of 9NC in patients with refractory solid tumors, a phase II study of 9NC in patients with advanced colon cancer, and a study evaluating the disposition of 9NC after administration of a single dose under fasting conditions. DNA was isolated from plasma and analyzed for variants in ABCB1, ABCC2, and ABCG2 genes. The ABCB1 1236C>T (n = 43), ABCB1 2677G>T/A (n = 43), ABCB1 3435C>T (n = 43), ABCC2 3972C>T (n = 39), and ABCG2 421C>A (n = 42) variants were analyzed using Pyrosequencing. The ABCG2 421C>A genotype significantly affected the pharmacokinetics of 9AC. The mean 9AC lactone AUC/dose for wild-type (n = 25) a...Continue Reading

References

Dec 1, 1995·Current Opinion in Genetics & Development·M Dean, R Allikmets
Dec 13, 1996·Annals of the New York Academy of Sciences·E A NatelsonJ S Stehlin
Aug 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R PazdurR Winn
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R L DrenglerM L Rothenberg
Apr 25, 2000·Biochemical and Biophysical Research Communications·E RocchiE Schneider
Oct 6, 2000·Cancer Chemotherapy and Pharmacology·S AkhtarJ Wright
Oct 19, 2000·Journal of the National Cancer Institute·J W JonkerA H Schinkel
Feb 24, 2001·Annals of the New York Academy of Sciences·C H Takimoto, R Thomas
Jan 16, 2002·American Journal of Human Genetics·Daniel J SchaidGregory A Poland
Jan 24, 2002·Journal of Bioenergetics and Biomembranes·S E BatesT Litman
Apr 9, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P SchöffskiJ Wanders
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M F KruijtzerJ H M Schellens
Jul 2, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E RaymondUNKNOWN New Drug Development Program (NDDP)
Nov 15, 2002·Cancer Biology & Therapy·Arthur B Pardee
Nov 15, 2002·Cancer Biology & Therapy·Wafik S El-Deiry
Nov 27, 2002·Cancer Chemotherapy and Pharmacology·Nadja E SchoemakerJos H Beijnen
Jul 2, 2004·Clinical Pharmacology and Therapeutics·Alex SparreboomHoward L McLeod
Sep 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Floris A de JongHoward L McLeod
Nov 4, 2004·Journal of the National Cancer Institute·Ron H J MathijssenAlex Sparreboom
Apr 8, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Federico InnocentiMark J Ratain

❮ Previous
Next ❯

Citations

Dec 31, 2010·Cancer Chemotherapy and Pharmacology·Zhao YanMeijun Liu
Feb 27, 2007·Cancer Metastasis Reviews·Robert W RobeySusan E Bates
Feb 27, 2007·Cancer Metastasis Reviews·Ying Huang
Jun 6, 2012·The Pharmacogenomics Journal·T D NguyenD L Kroetz
Mar 30, 2007·Annual Review of Biomedical Engineering·Sobin Kim, Ashish Misra
Aug 7, 2008·Pharmacogenomics·George Cusatis, Alex Sparreboom
Mar 28, 2008·Expert Opinion on Drug Metabolism & Toxicology·Ying HuangJeffrey Wang
Nov 30, 2010·Biochimica Et Biophysica Acta·Elena V BichenkovaKenneth T Douglas
Jan 13, 2009·Advanced Drug Delivery Reviews·Robert W RobeySusan E Bates
Aug 20, 2008·BJU International·Erin R GardnerWilliam D Figg
Aug 8, 2015·Acta Crystallographica. Section D, Biological Crystallography·Mark F RosenbergQingcheng Mao
Nov 1, 2008·Drug Metabolism and Pharmacokinetics·Woon Fei HoJon Deoon Lee
Sep 23, 2014·The AAPS Journal·Qingcheng Mao, Jashvant D Unadkat
Dec 23, 2006·Clinical Pharmacology and Therapeutics·F A de JongA Sparreboom
Sep 30, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Niall HeyesIan D Kerr
Jan 28, 2020·British Journal of Pharmacology·Robert Eckenstaler, Ralf A Benndorf
Jan 27, 2021·International Journal of Molecular Sciences·Song GaoDong Liang
Apr 4, 2021·International Journal of Molecular Sciences·László Homolya

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.